- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0.16%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 1 October, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan | 24.51% | 0.16% | -3.18% | -1.96% | 4.49% | 26.61% | - | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -12.49% | -1.3% | -3.53% | -6.07% | -7.61% | -12.86% | 4.04% | 10.56% | 14% | 13.47% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -8.41% | -0.51% | -2.15% | -6.2% | -4.8% | -4.64% | 7.63% | 7.46% | 11.9% | 11.24% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 20.71% | -0.29% | -3.55% | -3.34% | 2.86% | 20.19% | 22.83% | 17.78% | 26.13% | 14.6% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -2.81% | -1% | -2.42% | -3.71% | -6.43% | 0.48% | 11.75% | 15.13% | 18.63% | 15.01% |
| SBI COMMA Fund - DIRECT PLAN - Growth | 2.08% | -1.4% | -3.17% | -5.11% | -1.39% | 7.79% | 14.04% | 9.74% | 18.44% | 14.92% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | - | - | 52.37% | 1.73% |
Discrete returns (monthly)
| Month | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -1.38% | -4.65% | 6.99% | -4.36% | 7.84% | 5.11% | 6.59% | 3.59% | 3.8% | -2.11% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | 16.27% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 98.42% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 1.58% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Divis Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 9.54% | |
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 8.94% | |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.08% | |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 4.06% | |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.04% | |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 3.94% | |
| Aster DM Quality Care Limited | ASTERDM (INE914M01019) | Healthcare Services | 3.84% | |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 3.70% | |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 3.48% | |
| Acutaas Chemicals Limited | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 3.24% | |
| Ipca Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.23% | |
| Shilpa Medicare Ltd | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 3.10% | |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.06% | |
| Global Health Limited | MEDANTA (INE474Q01031) | Healthcare Services | 2.85% | |
| Rubicon Research Limited | RUBICON (INE506V01022) | Pharmaceuticals & Biotechnology | 2.82% | |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 2.37% | |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.34% | |
| Krishna Institute Of Medical Sciences Limited | KIMS (INE967H01025) | Healthcare Services | 2.25% | |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 2.24% | |
| Jupiter Life Line Hospitals Limited | (INE682M01020) | Healthcare Services | 1.94% | |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 1.93% | |
| Dr Reddys Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.90% | |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 1.90% | |
| Molbio Diagnostics Limited | (INE869T01028) | Healthcare Equipment & Supplies | 1.77% | |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.73% | |
| Wockhardt Ltd. | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 1.61% | |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.60% | |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 1.39% | |
| Thyrocare Technologies Ltd. | THYROCARE (INE594H01019) | Healthcare Services | 1.31% | |
| SYMBIOTEC PHARMALAB LIMITED**** | (INE899I01028) | Pharmaceuticals & Biotechnology | 1.21% | |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 1.18% | |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.09% | |
| CORONA REMEDIES LIMITED | CORONA (INE02ZQ01018) | Pharmaceuticals & Biotechnology | 1.07% | |
| Eris Lifesciences Ltd | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 1.06% | |
| Jubilant Pharmova Limited | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.85% | |
| BAJAJ HEALTHCARE LIMITED | BAJAJHCARE (INE411U01027) | Pharmaceuticals & Biotechnology | 0.57% | |
| Novartis India Ltd. | NOVARTIND (INE234A01025) | Pharmaceuticals & Biotechnology | 0.47% | |
| Laxmi Dental Limited | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 0.38% | |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 0.34% |
Portfolio data is as on date 31 August, 2026
NAV history
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 1 October, 2026 | 21.979 | 0.16% |
| 30 September, 2026 | 21.944 | -2% |
| 29 September, 2026 | 22.392 | 0.35% |
| 28 September, 2026 | 22.315 | -1.3% |
| 25 September, 2026 | 22.61 | -0.41% |
| 24 September, 2026 | 22.702 | -0.75% |
| 23 September, 2026 | 22.873 | 0.81% |
| 22 September, 2026 | 22.689 | -0.89% |
| 21 September, 2026 | 22.892 | 0.39% |
| 18 September, 2026 | 22.803 | 1.15% |
| 17 September, 2026 | 22.544 | 1.51% |
| 16 September, 2026 | 22.208 | -0.38% |
| 15 September, 2026 | 22.292 | -1.86% |
| 11 September, 2026 | 22.714 | -0.44% |
| 10 September, 2026 | 22.814 | 0.29% |
| 9 September, 2026 | 22.749 | 0.25% |
| 8 September, 2026 | 22.692 | 0.92% |
| 7 September, 2026 | 22.485 | 0.35% |
| 4 September, 2026 | 22.406 | -0.37% |
| 3 September, 2026 | 22.49 | 0.24% |
| 2 September, 2026 | 22.436 | 0.08% |
| 1 September, 2026 | 22.418 | -0.88% |
| 31 August, 2026 | 22.618 | 0.48% |
| 28 August, 2026 | 22.51 | -0.04% |
| 27 August, 2026 | 22.52 | 0.58% |
| 26 August, 2026 | 22.391 | 0.64% |
| 25 August, 2026 | 22.248 | 0.69% |
| 24 August, 2026 | 22.096 | 0.17% |
| 21 August, 2026 | 22.058 | -0.19% |
| 20 August, 2026 | 22.099 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 21.979 as on 1 October, 2026.What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 24.51% as on 1 October, 2026.What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 26.61% as on 1 October, 2026.What are top 10 holdings of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
Top 10 holdings of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are:- Divis Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.
- Max Healthcare Institute Limited
- Lupin Ltd.
- Cipla Ltd.
- Aster DM Quality Care Limited
- Neuland Laboratories Limited
- Anthem Biosciences Limited
- Acutaas Chemicals Limited
- Ipca Laboratories Ltd.
What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.